◼ Archived
Business
McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports
Option Care Health stock skyrocketed following a $5.8 billion buyout agreement with McKesson and CD&R.
2 trends tracked about this subject — the full history, oldest to newest below.
Option Care Health stock skyrocketed following a $5.8 billion buyout agreement with McKesson and CD&R.
McKesson has entered a definitive agreement to acquire Precision Medicine Group, LLC for $2.25 billion to expand its clinical research capabilities.